GlassScriptPhysician profile
Michael D Dykes
NPI 1164456240
$3,778.49
in general payments reported to CMS, 2019-2025
17 companies · $16.34 in 2025
The $16.34 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $259 · 2021: $272 · 2022: $2,577 · 2023: $82.28 · 2024: $45.96 · 2025: $16.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,643.24 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $432.75 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $252.04 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $76.73 | 2019-2021 | |
| Daiichi Sankyo INC. | $71.78 | 2019 | |
| Scilex Pharmaceuticals INC. | $48.46 | 2023-2024 | Ztlido |
| Novartis Pharmaceuticals Corporation | $44.81 | 2019-2020 | |
| Medtronic, INC. | $41.64 | 2021 | |
| Medtronic Vascular, INC. | $29.52 | 2020 | |
| Pfizer INC. | $27.27 | 2019-2020 | |
| Pacira Therapeutics, INC. | $18.36 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.99 | 2020 | |
| Amgen INC. | $16.79 | 2019 | |
| Redhill Biopharma INC. | $16.45 | 2021 | |
| Stryker Corporation | $16.34 | 2025 | Mild Device Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $12.39 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dykes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.